Innovation has been an essential part of the fabric of Johnson & Johnson for more than 135 years. Thanks to the incredible efforts of the tens of thousands of scientists, researchers, engineers, designers and clinicians, we have pioneered multiple breakthroughs to profoundly change the trajectory of health for humanity.
We advance innovation at Johnson & Johnson across many channels, as outlined in our Position on Innovation.
R&D Investment
(Millions)
Joseph J. Wolk
Executive Vice President, Chief Financial Officer, Johnson & Johnson
In 2022, we opened our latest state-of-the-art Janssen R&D facility, more than doubling our R&D presence in the San Francisco Bay Area. Located in one of the world’s most established global hubs for innovation, the campus bridges key scientific and technological capabilities by co-locating Janssen R&D and Johnson & Johnson Innovation, further integrating the Company into the Bay Area’s innovation ecosystem to strengthen and increase collaborations with innovators and accelerate growth.
invested in R&D over the past five years to deliver healthcare innovation to advance Our Purpose and improve lives.
Stacy Feld
Site Head, San Francisco Bay Campus and Regional Head, Johnson & Johnson Innovation, West North America
Throughout the world, we also expanded our J&J Centers for Global Health Discovery that advance healthcare science, targeting pressing challenges in global health in the regions of greatest need. In 2022, we launched two Satellite Centers—one in South Africa to address the threat of AMR and one in Singapore to focus on dengue and other flaviviruses.
Learn more about our Global Health Discovery Centers and about innovation across Johnson & Johnson Innovation, as well as Janssen R&D.
